当前位置：首页 SCI 期刊医学 Hpb(非官网)

HpbSCIE

国际简称：HPB 参考译名：血红蛋白

中科院分区
3区
CiteScore分区
Q2
JCR分区
Q1

基本信息：: ISSN：1365-182X; E-ISSN：1477-2574; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：ENGLAND; 出版商：John Wiley and Sons Inc.; 出版语言：English; 出版周期：12 issues/year; 出版年份：1998; 研究方向：GASTROENTEROLOGY & HEPATOLOGY-SURGERY

评价信息：: 影响因子：2.7; H-index：62; CiteScore指数：5.6; SJR指数：1.141; SNIP指数：1.15

发文数据：: Gold OA文章占比：75.97%; 研究类文章占比：87.21%; 年发文量：172; 自引率：0.0344...; 开源占比：0.1; 出版撤稿占比：0; 出版国人文章占比：0.08; OA被引用占比：0.0421...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Hpb期刊介绍

HPB is an international forum for clinical, scientific and educational communication.

Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.

Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.

HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.

Abstracted and Indexed in:

MEDLINE®

EMBASE

PubMed

Science Citation Index Expanded

Academic Search (EBSCO)

HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).

期刊简介Hpb期刊介绍

《Hpb》自1998出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：约1月
医学
SURGERY
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Hpb Cite Score数据

CiteScore：5.6
SJR：1.141
SNIP：1.15

学科类别	分区	排名	百分位
大类：Medicine 小类：Gastroenterology	Q2	44 / 167	73%
大类：Medicine 小类：Hepatology	Q2	30 / 82	64%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Hpb 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	SURGERY 外科 GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	3区 4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Hpb JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	64 / 143	55.6%
学科：SURGERY	SCIE	Q1	56 / 290	80.9%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	34 / 143	76.57%
学科：SURGERY	SCIE	Q2	74 / 290	74.66%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA227
CHINA MAINLAND82
Netherlands72
England70
Italy60
France57
Japan45
GERMANY (FED REP GER)37
Canada31
Australia26

本刊中国学者近年发表论文

1、Preoperative prediction model of microvascular invasion in patients with hepatocellular carcinoma
Author: Zhang, Jianfeng; Zeng, Fanxin; Jiang, Shijie; Tang, Hui; Zhang, Jian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 45-53. DOI: 10.1016/j.hpb.2022.08.007
2、Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China
Author: Yang, Shun-Chao; Liang, Lei; Wang, Ming-Da; Wang, Xian -Ming; Gu, Li -Hui; Lin, Kong-Ying; Zhou, Ya-Hao; Chen, Ting-Hao; Gu, Wei-Min; Li, Jie; Wang, Hong; Chen, Zhong; Li, Chao; Yao, Lan-Qing; Diao, Yong-Kang; Sun, Li -Yang; Zhang, Cheng-Wu; Zeng, Yong-Yi; Lau, Wan Yee; Huang, Dong-Sheng; Shen, Feng; Yang, Tian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 81-90. DOI: 10.1016/j.hpb.2022.09.002
3、Beyond successful hemostasis: CT findings and organ failure predict postoperative death in patients suffering from post-pancreatoduodenectomy hemorrhage
Author: Yang, Jie; Chen, Yonghua; Liu, Xubao; Zheng, Zhenjiang; Wang, Xing; Li, Yichen; Tan, Chunlu

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 252-259. DOI: 10.1016/j.hpb.2022.11.004
4、Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
Author: Lima, Henrique A.; Alaimo, Laura; Brown, Zachary J.; Endo, Yutaka; Moazzam, Zorays; Tsilimigras, Diamantis I.; Shaikh, Chanza; Resende, Vivian; Guglielmi, Alfredo; Ratti, Francesca; Aldrighetti, Luca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Hugh, Tom; Endo, Itaru; Shen, Feng; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 260-268. DOI: 10.1016/j.hpb.2022.11.008
5、Analysis of conditional survival in primary hepatocellular carcinoma after narrow-margin hepatectomy: a large- sample, dual-centre, retrospective study
Author: Kong, Jie; Huang, Tingfeng; Zhang, Jianxi; Tang, Shichuan; Liu, Hongzhi; Liu, Jingfeng; Zeng, Yongyi

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 179-188. DOI: 10.1016/j.hpb.2022.08.005
6、Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy
Author: Endo, Yutaka; Moazzam, Zorays; Alaimo, Laura; Lima, Henrique A.; Munir, Muhammad M.; Shaikh, Chanza F.; Guglielmi, Alfredo; Aldrighetti, Luca; Weiss, Matthew; Bauer, Todd W.; Alexandrescu, Sorin; Poultsides, George A.; Kitago, Minoru; Maithel, Shishir K.; Marques, Hugo P.; Martel, Guillaume; Pulitano, Carlo; Shen, Feng; Cauchy, Francois; Koerkamp, Bas G.; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 229-238. DOI: 10.1016/j.hpb.2022.10.011
7、Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma
Author: Endo, Yutaka; Lima, Henrique A.; Alaimo, Laura; Moazzam, Zorays; Brown, Zachary; Shaikh, Chanza F.; Ratti, Francesca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Workneh, Aklile; Guglielmi, Alfredo; Hugh, Tom; Aldrighetti, Luca; Shen, Feng; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 3, pp. 353-362. DOI: 10.1016/j.hpb.2022.12.009
8、Efficiency of percutaneous transhepatic cholangioscopy in the treatment of biliary complications after liver transplantation
Author: Yasen, Aimaiti; Feng, Jun; Liang, Run-Bin; Zhu, Can-Hua; Li, Jun; Liu, An-Zhong; Liu, Yan-Min; Wang, Guo-Ying

Journal: HPB. 2023; Vol. 25, Issue 4, pp. 463-471. DOI: 10.1016/j.hpb.2023.01.010